Clinical Trials Logo

Neonatal Seizures clinical trials

View clinical trials related to Neonatal Seizures.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02789176 Completed - Neonatal Seizures Clinical Trials

Continued Anticonvulsants After Resolution of Neonatal Seizures: a Patient-centered Comparative Effectiveness Study

Start date: October 2016
Phase:
Study type: Observational

The purpose of this study is to examine whether the duration of treatment with phenobarbital has an impact on neurodevelopmental and epilepsy outcomes, as well as parent and family well-being, after neonatal seizures.

NCT ID: NCT02229123 Completed - Neonatal Seizures Clinical Trials

Levetiracetam Treatment of Neonatal Seizures: Safety and Efficacy Phase II Study

LEVNEONAT-1
Start date: February 27, 2018
Phase: Phase 2
Study type: Interventional

LEVNEONAT is a multicentre French clinical trials with the aim to develop new treatment strategies for the treatment of neonatal seizures using Levetiracetam. The purpose of this study is to determine the correct dosing, safety and efficacy for intravenous levetiracetam as first line treatment in term newborn babies with seizures in hypoxic-ischemic encephalopathy context. This new anticonvulsivant drug is a promising treatment for seizures in newborns.

NCT ID: NCT02160171 Completed - Neonatal Seizures Clinical Trials

ANSeR- The Algorithm for Neonatal Seizure Recognition Study

ANSeR
Start date: April 2013
Phase: N/A
Study type: Observational

A Multicentre Clinical Evaluation of a Decision Support Algorithm for Neonatal Seizure Detection: ANSeR

NCT ID: NCT01720667 Completed - Neonatal Seizures Clinical Trials

Efficacy of Intravenous Levetiracetam in Neonatal Seizures

NEOLEV2
Start date: March 2013
Phase: Phase 1/Phase 2
Study type: Interventional

A new anticonvulsant, levetiracetam will be studied to treat seizures in newborn infants. Current treatments for the brain damaging complication of neonatal seizures are unsatisfactory. Monitoring for seizure detection will be tested at five (5) US sites and one (1) international site using the internet.

NCT ID: NCT01434225 Completed - Neonatal Seizures Clinical Trials

NEMO1:NEonatal Seizure Using Medication Off-patent

NEMO1
Start date: August 2011
Phase: Phase 1/Phase 2
Study type: Interventional

NEMO is a multicentre pan European clinical trial with the aim to develop new treatment strategies for the treatment of neonatal seizures using the loop diuretic bumetanide. There is evidence that bumetanide improves GABAergic function of the current standard drug, phenobarbitone. Bumetanide has been used as a diuretic in term and preterm babies for around thirty years. This trial should confirm that Bumetanide in addition to standard treatment will result in better seizures control.